Evidence map›Paper›PMID 23765132›Full record

ArticleThe Journal of investigative dermatology2014

Impaired wound repair in adult endoglin heterozygous mice associated with lower NO bioavailability.

Eduardo Pérez-Gómez, Mirjana Jerkic, Marta Prieto, Gaelle Del Castillo, Ester Martín-Villar, Michelle Letarte, Carmelo Bernabeu, Fernando Pérez-Barriocanal, Miguel Quintanilla, José M López-Novoa

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in The Journal of investigative dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Endoglin in the Spotlight to Treat Cancer.International journal of molecular sciences · 2021
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. The roles of endoglin gene in cerebrovascular diseases.Neuroimmunology and neuroinflammation · 2017
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Eduardo Pérez-GómezInstituto de Investigaciones Biomédicas Alberto Sols, Spanish National Research Council (CSIC), Autonomous University of Madrid (UAM), Madrid, Spain.
Mirjana JerkicRenal and Cardiovascular Physiopathology Unit, Instituto Reina Sofia de Investigación, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain; Molecular Structure and Function Program, Hospital for Sick Children, Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Marta PrietoRenal and Cardiovascular Physiopathology Unit, Instituto Reina Sofia de Investigación, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain.
Gaelle Del CastilloInstituto de Investigaciones Biomédicas Alberto Sols, Spanish National Research Council (CSIC), Autonomous University of Madrid (UAM), Madrid, Spain.
Ester Martín-VillarInstituto de Investigaciones Biomédicas Alberto Sols, Spanish National Research Council (CSIC), Autonomous University of Madrid (UAM), Madrid, Spain.
Michelle LetarteMolecular Structure and Function Program, Hospital for Sick Children, Department of Immunology, University of Toronto, Toronto, Ontario, Canada.
Carmelo BernabeuCentro de Investigaciones Biológicas, CSIC, and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain.
Fernando Pérez-BarriocanalRenal and Cardiovascular Physiopathology Unit, Instituto Reina Sofia de Investigación, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain.
Miguel QuintanillaInstituto de Investigaciones Biomédicas Alberto Sols, Spanish National Research Council (CSIC), Autonomous University of Madrid (UAM), Madrid, Spain.
José M López-NovoaRenal and Cardiovascular Physiopathology Unit, Instituto Reina Sofia de Investigación, Department of Physiology and Pharmacology, University of Salamanca, Salamanca, Spain. Electronic address: jmlnovoa@usal.es.
Universidad Autónoma de Madrid · ESUniversidad de Salamanca · ESCentro de Investigaciones Biológicas Margarita Salas · ESHospital for Sick Children · CAInstituto de Investigaciones Biomédicas Sols-Morreale · ESSickKids Foundation · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endoglin (Eng) is a transmembrane glycoprotein that is mainly expressed in endothelial cells, but it is also present in the epidermis and skin appendages. To address the role of Eng in cutaneous wound healing, we compared the kinetics of reepithelialization in Eng heterozygous null (Eng(+/-)) mice and their normal littermates (Eng(+/+)) following skin wounds. The wound area was significantly larger in Eng(+/-) than in Eng(+/+) mice from 2 to 8 days after injury; overall wound closure was delayed by 1 to 2 days. In Eng(+/-) mice, keratinocytes at the wound edges exhibited impaired proliferation but were more migratory, as shown by their elongated morphology and increased keratin 17 expression. Inhibition of nitric oxide (NO) synthesis delayed healing in Eng(+/+) but not in Eng(+/-) mice. Administration of the NO donor LA-803 accelerated wound closure in Eng(+/-) mice, with no effect on normal littermates. The acute stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA) enhanced Eng expression in mouse epidermal keratinocytes in vivo and in vitro associated with hyperproliferation. Similarly, the skin of Eng(+/-) mice failed to mount a hyperplastic response to acute stimulation with TPA. These results demonstrate an important involvement of Eng in wound healing that is associated with NO bioavailability.

Indexed as

Age FactorsAnimalsCarcinogensCell ProliferationEndoglinEpidermisEpithelial CellsFemaleHeterozygoteHyperplasiaIntracellular Signaling Peptides and ProteinsMiceMice, Inbred C57BLMice, KnockoutNitric OxideTetradecanoylphorbol AcetateCarcinogensEndoglinEng protein, mouseIntracellular Signaling Peptides and ProteinsNitric OxideTetradecanoylphorbol Acetate

Identifiers

PMID23765132
OpenAlexW2078989098

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.